Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
Revicki DA, Menter A, Feldman S, Kimel M, Harnam N, Willian MK. Revicki DA, et al. Among authors: willian mk. Health Qual Life Outcomes. 2008 Oct 2;6:75. doi: 10.1186/1477-7525-6-75. Health Qual Life Outcomes. 2008. PMID: 18831744 Free PMC article. Clinical Trial.
Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
Yarlas A, D'Haens G, Willian MK, Teynor M. Yarlas A, et al. Among authors: willian mk. Inflamm Bowel Dis. 2018 Jan 18;24(2):450-463. doi: 10.1093/ibd/izx041. Inflamm Bowel Dis. 2018. PMID: 29361097 Free PMC article. Clinical Trial.
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis.
Revicki D, Willian MK, Saurat JH, Papp KA, Ortonne JP, Sexton C, Camez A. Revicki D, et al. Among authors: willian mk. Br J Dermatol. 2008 Mar;158(3):549-57. doi: 10.1111/j.1365-2133.2007.08236.x. Epub 2007 Nov 28. Br J Dermatol. 2008. PMID: 18047521 Clinical Trial.
38 results